#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Prostate cancer+2

Recruiting

Registered drugNo placebo

Long-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Niraparib Tosilate Monohydrate

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with High-Risk Localized or Locally Advanced Prostate Cancer Eligible for Surgery

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Lutetium (177Lu) Vipivotide Tetraxetan

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on the Use of [18F]PSMA-1007 PET/CT Imaging for Detecting Prostate Cancer in Patients with Newly Diagnosed High-Risk or Very-High-Risk Conditions

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:(2S)-2-[[(1S)-1-Carboxy-5-[[(2S)-2-[[4-[[[(2S)-4-Carboxy-2-[[(2S)-4-Carboxy-2-[(6-(18F)Fluoranylpyridine-3-Carbonyl)Amino]Butanoyl]Amino]Butanoyl]Amino]Methyl]Benzoyl]Amino]-3-Naphthalen-2-Ylpropanoyl]Amino]Pentyl]Carbamoylamino]Pentanedioic Acid

Contact Research Centre

Prostate cancer+1

Recruiting

Registered drugNo placebo

Study on How Degarelix and Drug Combination Affect Gut Health in Patients with Prostate Cancer or Benign Prostate Hyperplasia

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Degarelix

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study of Apalutamide and Radiation Therapy for Patients with Low Burden Metastatic Hormone Sensitive Prostate Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on the Effect of Metastasis-Directed Therapy with Lutetium (177Lu) Zadavotide Guraxetan in Patients with Advanced Prostate Cancer and Up to 5 Progressive Lesions

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study Comparing 177Lu-PSMA-I&T with Apalutamide, Enzalutamide, and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on Estradiol and Exercise to Reduce Side Effects of Androgen Deprivation Therapy in Prostate Cancer Patients

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Estradiol

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on How Abiraterone Affects Oxycodone in Men with Prostate Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Oxycodone Hydrochloride

Contact Research Centre

Prostate cancer+1

Recruiting

Registered drug

Study on Atorvastatin's Effect on Prostate Cancer Progression in Patients Undergoing Androgen Deprivation Therapy

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Prostate cancer

Recruiting

InvestigationalNo placebo

Study on the Use of 18F-PSMA-1007 PET/MRI for Diagnosing Significant Prostate Cancer in Patients with Suspected Prostate Cancer

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.